Skip to main content

Table 7 Estimated bone marrow absorbed doses for therapeutic bone radiopharmaceuticals [5, 41].

From: Re-HEDP : pharmacokinetic characterization, clinical and dosimetric evaluation in osseous metastatic patients with two levels of radiopharmaceutical dose

 

(rad/mCi)

(mGy/MBq)

32P

14

3.8

89Sr

50

13.5

153Sm-EDTMP

6

1.6

186Re-HEDP

3

0.8

188Re-HEDP

2

0.5